Home » ALLERGAN RECEIVES PAN EUROPEAN LICENSE FOR GANFORT
ALLERGAN RECEIVES PAN EUROPEAN LICENSE FOR GANFORT
Allergan, Inc. today announced that it has received the license from the European Commission to market Ganfort, Allergan's Lumigan/timolol combination product (bimatoprost/timolol ophthalmic solution) for the treatment of glaucoma, in the European Union.
Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20060525005229&newsLang=en)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May